- Published:
The Effect of Carbon Tetrachloride (CCl4) Induced Liver Damage on the Volume of Distribution, the Elimination Half-Life and body Clearance of Antipyrine and Warfarin in Rabbits
Virkningen af tetraklorkulstof (CCl4) induceret leverbeskadigelse på fordelingsvolumen, halveringstid og body clearance af antipyrin og warfarin hos kaniner
Acta Veterinaria Scandinavica volume 20, pages 429–437 (1979)
Abstract
The pharmacokinetics of antipyrine and warfarin were investigated in rabbits with carbon tetrachloride (CCl4) induced liver damage. The volume of distribution of antipyrine was slightly increased whereas it was markedly reduced for warfarin when estimated 24 h after the CCl4 injection. Twenty-four h after the CCl4 injection, the elimination rate constant, the half-life and the body clearance were significantly changed for both compounds. The effect of CCl4 on the pharmacokinetic parameters of antipyrine persisted 10 days after the CCl4 injection, whereas the pharmacokinetic parameters of warfarin were normalized at that time. The clinical importance of the changes of drug pharmacokinetics in liver diseases is mentioned, and it is concluded that each drug may behave differently, so that a drug has to be investigated separately in every disease for which the drug is prescribed.
Sammendrag
Fordelingsvolumen, eliminationskonstant, halveringstid og body clearance for antipyrin og warfarin blev bestemt hos normale kaniner og hos de samme kaniner 24 timer og 10 dage efter injektion af tetra-klorkulstof (GG14) 0,4 ml/kg lgv. eller 0,2 ml/kg Igv. Fordelingsvolu-menet for antipyrin var større hos kaninerne 24 timer efter GC14 injektionen, og ændringen kunne stadig påvises 10 dage efter GG14 injektionen. Warfarins fordelingsvolumen var signifikant mindre hos kaninerne 24 timer efter GG14 injektionen sammenlignet med kontrolværdien, men 10 dage efter GG14 infektionen var fordelingsvolumenet igen normaliseret. Eliminationskon & tanten, halveringstiden og body clearance for både antipyrin og warfarin ændredes signifikant 24 timer efter GG14 injektionen. Kun for antipyrin kunne der påvises ændringer i de tre parametre 10 dage efter injektionen.
Den kliniske betydning af ændringer i lægemidlers farmakokinetik ved leversygdomme påpeges. Mulighederne for at anvende CG14 inducerede leverskader som model ved studier af farmakokinetiske konstanter ved leversygdomme i veterinærmedicinen fremhæves.
References
Alfieri-Rolla, G. & G. Segre: The effect of carbon tetrachloride on the kinetics of bromsulphalein clearance in the rabbit. Europ. J. Pharmacol. 1968, 3, 330–336.
Brodie, B. B., J. Axelrod, R. Soberman & B. B. Levy: The estimation of antipyrine in biological materials. J. biol. Chem. 1949, 179, 25–29.
Corn, M. & R. Berberich: Rapid fluorometric assay for plasma warfarin. Clin. Chem. 1967, 13, 126–131.
Kato, R.: Drug metabolism under pathological and abnormal physiological states in animals and man. Xenobiotica 1977, 7, 25–92.
Klotz, U.: Influence of liver disease on the elimination of drugs. Europ. J. Drug Metab. Pharmacokinetics 1976a, 3, 129–140.
Klotz, U.: Pathophysiological and disease-induced changes in drug distribution volume: Pharmacokinetic implication. Clin. Pharmacokin. 1976 b, 1, 204–218.
Kunii, O., K. Fukaya & K. Mashimo: Biotransformation of the antibiotics in the patients and animals with liver impairment. Chemotherapy 1975, 4, 159–164.
Ladefoged, O.: Absorptionen fra peritonealhulen, Eksperimentelle undersøgelser over intraperitonealt applicerede la3gemidlers farmakokinetik. (Absorption from the peritoneal cavity). Ph. D. Thesis, Copenhagen 1975, 79 pp.
Ladefoged, O.: Endotoxin induced changes in the pharmacokinetics of warfarin in rabbits. Acta vet. scand. 1978, 19, 479–486.
Pessayre, D., H. Allemand & J. P. Benhamou: Effets des maladies du foi et des voies biliaires sur le metabolisme des médicaments. (Effects of hepato-biliary diseases on drug metabolism). Nouv. Press, med, 1977, 6, 3209–3219.
Shand, D. G.: Drug disposition in liver disease. New Engl. J. Med. 1977, 296, 1527–1528,
Siegers, C. P., O. Strubelt & A. Schütt: Relations between hepatotoxicity and pharmacokinetics of paracetamol in rats and mice. Pharmacology 1978, 16, 273–278.
Wilkinson, G. R. & S. Schenker: Drug disposition and liver disease. Drug Metabol. Rev. 1975, 4, 139–175.
Wilkinson, G. R. & S. Schenker: Effects of liver disease on drug disposition in man. Riochem. Pharmacol. 1976, 25, 2675–2681.
Willson, R. A. & F. E. Hart: Effect of experimental hepatic injury on in vitro drugmetabolizing enzyme activities in the rat. Gastroenterology 1977, 73, 691–696.
Author information
Authors and Affiliations
Additional information
The work was supported by the Danish Agricultural and Veterinary Research Council.
Rights and permissions
About this article
Cite this article
Ladefoged, O. The Effect of Carbon Tetrachloride (CCl4) Induced Liver Damage on the Volume of Distribution, the Elimination Half-Life and body Clearance of Antipyrine and Warfarin in Rabbits. Acta Vet Scand 20, 429–437 (1979). https://doi.org/10.1186/BF03546604
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1186/BF03546604